4
Changes in Ownership
Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-17-002501
Options or other derivatives
- CEO and Interim CFO acquired 250,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
DAVE KAUSHIK J · CEO and Interim CFO
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-03-14 | Grant or award : show line 1 in the form Options to purchase common stock | +250,000 | $1.39 | $347,500 | 250,000 | D |
Loading xslF345X03/f4031417dave_actinium.xml…